UK Markets closed

Adverum Biotechnologies, Inc. (0HA3.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
5.90+4.28 (+264.65%)
At close: 03:22PM GMT
Full screen
Previous close1.62
Open1.57
Bid0.00 x N/A
Ask0.00 x N/A
Day's range1.57 - 1.57
52-week range1.57 - 1.57
Volume2,400
Avg. volumeN/A
Market cap473.5M
Beta (5Y monthly)1.13
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Business Wire

    The Sonic Fund II, L.P. Comments on Preliminary Voting Results of Adverum Annual Meeting

    The Sonic Fund II, L.P. ("Sonic"), which beneficially owns approximately 6.8% of the outstanding common stock of Adverum Biotechnologies, Inc. (NASDAQ: ADVM) (the "Company" or "Adverum"), today issued the following statement regarding the preliminary voting results from the Company’s 2021 Annual Meeting of Stockholders (the "2021 Annual Meeting").

  • Business Wire

    The Sonic Fund II, L.P. Issues Statement to Adverum Stockholders

    The Sonic Fund II, L.P. ("Sonic"), which beneficially owns approximately 6.8% of the outstanding common stock of Adverum Biotechnologies, Inc. (NASDAQ: ADVM) (the "Company" or "Adverum"), today issued the following statement regarding the Company’s upcoming 2021 Annual Meeting of Stockholders (the "2021 Annual Meeting"), which will be held on Wednesday, May 12, 2021.

  • Business Wire

    The Sonic Fund II, L.P. Reminds Adverum Stockholders to Vote for Its Three Independent Director Nominees at May 12 Annual Meeting

    The Sonic Fund II, L.P. ("Sonic"), which beneficially owns approximately 6.8% of the outstanding common stock of Adverum Biotechnologies, Inc. (NASDAQ: ADVM) (the "Company" or "Adverum"), today reminded stockholders to make their voices heard at the Company’s upcoming 2021 Annual Meeting of Stockholders (the "2021 Annual Meeting"), which will be held on Wednesday, May 12, 2021.